Akili Grabs CE Mark for Children’s Digital ADHD Treatment Post author:Sam Post published:June 22, 2020 Post category:Devices & Diagnostics Letter The FDA last week cleared EndeavorRx for marketing in the U.S. Source: Devices & Diagnostics Letter You Might Also Like EU Signs COVID-19 Vaccine Supply Deal With Sanofi/GSK September 20, 2020 Gilead’s Remdesivir Gains Orphan Drug Status as Possible COVID-19 Treatment March 24, 2020 FDA Warns Danish Drugmaker for Testing Failures March 24, 2020
